LABT Appoints Study Chair
Lakewood-Amedex Biotherapeutics appoints Dr. David G. Armstrong as study chair for Phase 2a trial of Nu-3 in infected diabetic foot ulcers
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.